Welcome to our dedicated page for Iris Acquisition II news (Ticker: IRABU), a resource for investors and traders seeking the latest updates and insights on Iris Acquisition II stock.
Iris Acquisition Corp II reports SPAC-related developments tied to its blank-check issuer status. Recurring news categories include shareholder voting matters, capital-structure disclosure, governance matters, and SPAC or security-structure disclosures.
Updates about IRABU are centered on corporate mechanics rather than operating results from a commercial business segment. The issuer's news profile reflects the public-company framework of an acquisition vehicle, including voting and governance topics associated with the SPAC structure.
Iris Acquisition Corp II (NYSE: IRABU) announced that, commencing February 24, 2026, holders of units from its IPO may elect to separately trade Class A ordinary shares and warrants.
Separated Class A shares will trade as IRAB and separated warrants as IRAB WS on the NYSE. Units not separated will continue trading as IRAB U. No fractional warrants will be issued; only whole warrants will trade. Holders must contact Odyssey Transfer & Trust Company to effect separation. A registration statement was declared effective on January 30, 2026.
Iris Acquisition Corp II (NYSE: IRABU) priced a $150,000,000 initial public offering of 15,000,000 units at $10.00 per unit, each unit containing one Class A ordinary share and one-half redeemable warrant. Whole warrants exercisable at $11.50 arise after the SPAC combination or 12 months post-Effective Date.
Units are expected to begin trading on NYSE as IRABU on February 3, 2026, with separate trading of shares and warrants as IRAB and IRABW. The offering is expected to close February 4, 2026, with a 45-day 2,250,000-unit over-allotment option for the underwriter.